Skip to Main Content
Back to News

Lobbying Update: $50,000 of MCKESSON CORPORATION lobbying was just disclosed

None

$50,000 of MCKESSON CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency."

You can find more data on corporate lobbying on Quiver Quantitative.

MCK Congressional Stock Trading

Members of Congress have traded $MCK stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $MCK stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MCK Insider Trading Activity

MCK Insider Trades

MCK insiders have traded $MCK stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $MCK stock by insiders over the last 6 months:

  • BRIAN S. TYLER (Chief Executive Officer) has made 0 purchases and 4 sales selling 62,601 shares for an estimated $43,894,118.
  • BRITT J. VITALONE (EVP & CFO) has made 0 purchases and 3 sales selling 8,946 shares for an estimated $6,416,603.
  • THOMAS L RODGERS (EVP, Chief Strategy & BDO) has made 0 purchases and 2 sales selling 3,401 shares for an estimated $2,425,046.
  • NAPOLEON B JR RUTLEDGE (SVP, Controller & CAO) has made 0 purchases and 5 sales selling 2,016 shares for an estimated $1,430,403.
  • LEANN B SMITH (EVP & Chief HR Officer) has made 0 purchases and 3 sales selling 1,750 shares for an estimated $1,255,151.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MCK Hedge Fund Activity

We have seen 780 institutional investors add shares of MCK stock to their portfolio, and 757 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MCK Analyst Ratings

Wall Street analysts have issued reports on $MCK in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • JP Morgan issued a "Overweight" rating on 09/26/2025
  • Citigroup issued a "Buy" rating on 09/24/2025
  • Evercore ISI Group issued a "Outperform" rating on 09/24/2025
  • Morgan Stanley issued a "Overweight" rating on 09/24/2025
  • Deutsche Bank issued a "Buy" rating on 09/24/2025
  • Leerink Partners issued a "Outperform" rating on 09/24/2025
  • UBS issued a "Buy" rating on 09/24/2025

To track analyst ratings and price targets for MCK, check out Quiver Quantitative's $MCK forecast page.

MCK Price Targets

Multiple analysts have issued price targets for $MCK recently. We have seen 12 analysts offer price targets for $MCK in the last 6 months, with a median target of $854.5.

Here are some recent targets:

  • Brian Tanquilut from Jefferies set a target price of $900.0 on 10/14/2025
  • Lisa Gill from JP Morgan set a target price of $853.0 on 09/26/2025
  • Stephen Baxter from Wells Fargo set a target price of $816.0 on 09/24/2025
  • Elizabeth Anderson from Evercore ISI Group set a target price of $825.0 on 09/24/2025
  • Steven Valiquette from Mizuho set a target price of $770.0 on 09/24/2025
  • Daniel Grosslight from Citigroup set a target price of $860.0 on 09/24/2025
  • Kevin Caliendo from UBS set a target price of $860.0 on 09/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles